Sihao Liu

Title: Sihao Liu: Innovator in Metabolic Disorder Research

Introduction

Sihao Liu is a prominent inventor based in San Diego, California. He has made significant contributions to the field of metabolic disorders through his innovative research and patented inventions. His work focuses on developing solutions to reduce blood glucose levels, which is crucial for managing diabetes and other related conditions.

Latest Patents

Sihao Liu holds a patent for mutant proteins of fibroblast growth factor 1 (FGF1) that selectively activate FGFR1B to reduce blood glucose. This patent provides a detailed disclosure of FGF1 mutant proteins that selectively bind to and activate FGFR1b. Additionally, it includes nucleic acid molecules encoding these proteins, as well as vectors and cells that incorporate such nucleic acids. The methods outlined in the patent demonstrate how these FGF1 mutants can be utilized to lower blood glucose levels in mammals and treat metabolic disorders effectively.

Career Highlights

Sihao Liu is affiliated with the Salk Institute for Biological Studies, a leading research institution known for its groundbreaking work in biological sciences. His role at the institute allows him to collaborate with other esteemed scientists and contribute to significant advancements in health and medicine.

Collaborations

Some of Sihao Liu's notable coworkers include Ronald Mark Evans and Michael Downes. Their collaborative efforts enhance the research environment and foster innovation in the study of metabolic disorders.

Conclusion

Sihao Liu's contributions to the field of metabolic disorder research through his patented inventions highlight his role as an influential inventor. His work not only advances scientific understanding but also offers potential therapeutic solutions for managing blood glucose levels.